Qiang, W
Antelope, O
Zabriskie, M S
Pomicter, A D
Vellore, N A
Szankasi, P
Rea, D
Cayuela, J M
Kelley, T W
Deininger, M W
O’Hare, T
Article History
First Online: 18 August 2017
Competing interests
: TWK has financial interests to declare: Novartis speaker's bureau, Novartis advisory board. DR receives honoraria from BMS, Novartis, Incyte and Pfizer for non-promotional scientific lectures or advisory boards and is an investigator of Novartis-sponsored CABL001X2101 phase I trial. The remaining authors declare no conflict of interest.